Evidence map›Paper›PMID 36508132›Full record

ArticleTranslational stroke research2023

Recombinant Human Perlecan DV and Its LG3 Subdomain Are Neuroprotective and Acutely Functionally Restorative in Severe Experimental Ischemic Stroke.

Ifechukwude Joachim Biose, Ibolya Rutkai, Bryan Clossen, Gary Gage, Kenneth Schechtman, H Davis Adkisson, Gregory J Bix

Open access · hybridAbstract read
In one paragraph

Article in Translational stroke research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ifechukwude Joachim BioseDepartment of Neurosurgery, Clinical Neuroscience Research Center, Tulane University School of Medicine, New Orleans, LA, 70112, USA.
Ibolya RutkaiDepartment of Neurosurgery, Clinical Neuroscience Research Center, Tulane University School of Medicine, New Orleans, LA, 70112, USA.
Bryan ClossenStream Biomedical, Inc., 2450 Holcombe, Suite J, Houston, TX, 77021, USA.
Gary GageStream Biomedical, Inc., 2450 Holcombe, Suite J, Houston, TX, 77021, USA.
Kenneth SchechtmanDivision of Biostatistics, Washington University School of Medicine, St. Louis, MO, 63110, USA.
H Davis AdkissonStream Biomedical, Inc., 2450 Holcombe, Suite J, Houston, TX, 77021, USA. haiv@streambiomed.com.ORCID http://orcid.org/0000-0001-6507-0016
Gregory J BixDepartment of Neurosurgery, Clinical Neuroscience Research Center, Tulane University School of Medicine, New Orleans, LA, 70112, USA. gbix@tulane.edu.ORCID http://orcid.org/0000-0002-8969-9553
Tulane University · USVisionQuest Biomedical (United States) · USWashington University in St. Louis · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

Despite recent therapeutic advancements, ischemic stroke remains a major cause of death and disability. It has been previously demonstrated that  ~ 85-kDa recombinant human perlecan domain V (rhPDV) binds to upregulated integrin receptors (α2β1 and α5β1) associated with neuroprotective and functional improvements in various animal models of acute ischemic stroke. Recombinant human perlecan laminin-like globular domain 3 (rhPDV

Indexed as

Brain IschemiaIschemic StrokeNeuroprotective AgentsStrokeAnimalsDisease Models, AnimalHeparan Sulfate ProteoglycansHumansInfarctionInfarction, Middle Cerebral ArteryIntegrinsMaleMiceHeparan Sulfate ProteoglycansIntegrinsNeuroprotective AgentsperlecanBasement membraneLG3Neuroprotection and acute ischemic strokePerlecanPerlecan domain V

Identifiers

PMID36508132
PMCPMC10258221
OpenAlexW4311201185

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.